Prior authorization (PA) is one of the biggest bottlenecks facing Spravato® providers today. For many practices, it’s not just an administrative burden, it’s a barrier that delays patient care, disrupts treatment plans, and impacts revenue.
Industry data shows that 66% of physicians report waiting at least two business days for PA decisions, and 27% experience waits of a week or longer. For a treatment like Spravato®, where timely care can make a life-changing difference for patients with treatment-resistant depression, these delays are unacceptable.
At Finnastra, we understand that efficient, compliant prior authorization workflows are essential to delivering better patient outcomes and maintaining financial stability. As a leading Spravato Billing Company, we’ve developed a playbook that dramatically reduces PA delays, helping providers start treatments faster while minimizing administrative stress.
Spravato® treatment involves a strict REMS program and significant payer scrutiny. A single delay can cause ripple effects across a practice:
Example: A mid-sized psychiatric clinic with 50 active Spravato® patients experienced average PA turnaround times of 12–15 days with their previous billing provider. This resulted in $50,000+ in lost monthly revenue due to delayed treatment starts and expired authorizations.
Prior authorization for Spravato® is far more complex than standard psychiatric medications. Most general billing firms lack the specific expertise needed to handle:
Without deep knowledge of these rules, generic firms submit incomplete or inaccurate PA requests, triggering denials or endless back-and-forth with payers.
At Finnastra, our Spravato Billing Services are designed to simplify prior authorization while keeping providers compliant. Here’s how we do it:
We build customized intake forms to capture all necessary clinical information upfront, eliminating the need for repeat submissions.
Our proprietary database tracks payer-specific rules for Spravato® coverage across Medicare, Medicaid, and commercial plans.
Every Finnastra client is assigned a dedicated Spravato® PA specialist who knows their practice, patients, and payers inside out.
Expired authorizations are a common source of denied claims.
A Delaware-based clinic transitioned to Finnastra after months of frustration with their prior billing company.
Before Finnastra:
After Finnastra:
If you answered “no” to any of these, your practice may already be losing revenue and risking patient care delays.
When you work with a dedicated Spravato Billing Company like Finnastra, you’re choosing a partner that understands both the clinical urgency and the financial complexity of Spravato®.
Our team doesn’t just process claims, we become an extension of your practice, ensuring every patient gets approved quickly, every claim is fully reimbursed, and every treatment session is documented for compliance.
As a leader in Spravato Billing Services, Finnastra also brings expertise in TMS Billing and Ketamine Billing, giving us a comprehensive understanding of mental health reimbursement challenges.
Here’s what you can expect:
Prior authorization delays don’t just hurt your practice’s revenue, they delay care for patients who need it most. By implementing Finnastra’s proven PA playbook, you can eliminate administrative chaos, speed up treatment initiation, and build a scalable, profitable Spravato® program.
Don’t let payer red tape hold your practice back.
Partner with Finnastra and transform your PA process today.
Learn more about how Finnastra’s Spravato Billing Services can streamline your practice: Spravato Billing Services